Clinical Trial Update: Fecal Microbiota Transplant for Inflammatory Bowel Disease [EARLY_Phase 1]

View source ↗

Summary

This document reports that the EARLY Phase 1 trial of fecal microbiota transplant for inflammatory bowel disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: University of California, San Francisco | Conditions: Inflammatory Bowel Disease | EARLY_Phase 1 | Status: COMPLETED